Skip to main content

BCAN

Developmental stage

Expressed between 6 and 19 weeks post-conception (WPC) in the outer neuroblastic zone, inner neuroblastic zone, and inner plexiform layer of the retina (at protein level) (PubMed:29777959). Expressed at the surface ectoderm at 6 WPC and the neural retinal at 6 to 8 WPC (at protein level) (PubMed:29777959). Expressed in the interphotoreceptor matrix and abundantly in developing photoreceptors between 12 and 19 WPC (at protein level) (PubMed:29777959). Isoform 1: Highly expressed from birth through 8 years of age and is down-regulated by 20 years of age to low levels that are maintained in the normal adult cortex (PubMed:11054543). Isoform 2: Expressed at uniformly low levels throughout development (PubMed:11054543).

Function

May play a role in the terminally differentiating and the adult nervous system during postnatal development. Could stabilize interactions between hyaluronan (HA) and brain proteoglycans.

Post-translational modifications

Contains mostly chondroitin sulfate (By similarity). O-glycosylated with a core 1 or possibly core 8 glycan.

Sequence similarities

Belongs to the aggrecan/versican proteoglycan family.

Tissue specificity

Expressed in the retina, specifically in the inner nuclear layer, inner plexiform layer and ganglion cell layer (at protein level).

Cellular localization

  • Isoform 1
  • Secreted
  • Extracellular space
  • Extracellular matrix
  • Isoform 2
  • Membrane
  • Lipid-anchor
  • GPI-anchor

Alternative names

  • Brevican core protein
  • Brain-enriched hyaluronan-binding protein
  • Chondroitin sulfate proteoglycan 7
  • BEHAB
  • BCAN
  • BEHAB
  • CSPG7
  • UNQ2525/PRO6018

Target type

Proteins

Primary research area

Neuroscience

Molecular weight

99118Da